Genocea Biosciences
GNCA
#10614
Rank
โ‚ฌ0 M
Marketcap
0,00008589ย โ‚ฌ
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)

EPS for Genocea Biosciences (GNCA)

EPS in 2022 (TTM): -0,46ย โ‚ฌ

According to Genocea Biosciences 's latest financial reports the company's current EPS (TTM) is -0,45ย โ‚ฌ. In 2021 the company made an earnings per share (EPS) of -0,41ย โ‚ฌ an increase over its 2020 EPS that were of -1,00ย โ‚ฌ.

EPS history for Genocea Biosciences from 2014 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-0,46ย โ‚ฌ11.64%
2021-0,41ย โ‚ฌ-58.62%
2020-1,00ย โ‚ฌ-48.21%
2019-1,92ย โ‚ฌ
2017-13,60ย โ‚ฌ13.14%
2016-12,02ย โ‚ฌ-3.31%
2015-12,44ย โ‚ฌ-23.31%
2014-16,22ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Agenus
AGEN
-2,67ย โ‚ฌ 498.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
1,82ย โ‚ฌ-507.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,52ย โ‚ฌ-1,560.34%๐Ÿ‡บ๐Ÿ‡ธ USA
iBio
IBIO
-1,96ย โ‚ฌ 338.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,48ย โ‚ฌ-430.77%๐Ÿ‡บ๐Ÿ‡ธ USA